Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06904612Completed

Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels

Role: collaborator

NCT02832089Phase 3Completed

Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

Role: lead

NCT01776294Completed

Prehypertension Among Medical Students in Visakhapatnam and Association With Cardiovascular Risk Factors

Role: lead

NCT01346956Completed

Acute Cardiovascular Effects of Cigarette Smoking

Role: lead

All 4 trials loaded